INTERFERON alpha2 (IFN alpha2) as anti-angiogenic agent for the treatment of neovascular age-related macular degeneration: a pilot study

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-007744-98

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The aim of this study is to examine the action of Interferon 2 as anti-angiogenic agent for the treatment of neovascular age-related macular degeneration


Critère d'inclusion

  • Neovascular Age-related macular degeneration

Liens